Novel imaging technologies for genetic diagnoses in the inborn errors of metabolism

Abstract

Many inborn errors of metabolism and genetic disorders affect the brain. The brain biochemistry may differ from that in the periphery and is not accessible by simple blood and urine sampling. Therefore, neuroimaging has proven to be a valuable tool to not only evaluate the brain structure, but also biochemistry, blood flow and function. Neuroimaging in patients with inborn errors of metabolism can include additional sequences in addition to T1 and T2-weighted imaging because in early stages, there may be no significant findings on the routine sequnces due to the lack of sensitivity or the evolution of abnormalities lags behind the ability of the imaging to detect it. In addition, findings on T1 and T2-weighted imaging of several inborn errors of metabolism may be non-specific and be seen in other non-genetic conditions. Therefore, additional neuroimaging modalities that have been employed including diffusion tensor imaging (DTI), magnetic resonance spectroscopy, functional MRI (fMRI), functional near infrared spectroscopy (fNIRS), or positron emission tomography (PET) imaging may further inform underlying changes in myelination, biochemistry, and functional connectivity. The use of Magnetic Resonance Spectroscopy in certain disorders may add a level of specificity depending upon the metabolite levels that are abnormal, as well as provide information about the process of brain injury (i.e., white matter, gray matter, energy deficiency, toxic buildup or depletion of key metabolites). It is even more challenging to understand how genetic or metabolic disorders contribute to short and/or long term changes in cognition which represent the downstream effects of IEMs. In order to image “cognition” or the downstream effects of a metabolic disorder on domains of brain function, more advanced techniques are required to analyze underlying fiber tracts or alternatively, methods such as fMRI enable generation of brain activation maps after both task based and resting state conditions. DTI can be used to look at changes in white matter tracks. Each imaging modality can explore an important aspect of the anatomy, physiology or biochemisty of the central nervous system. Their properties, pros and cons are discussed in this article. These imaging modalities will be discussed in the context of several inborn errors of metabolism including Galactosemia, Phenylketonruia, Maple syrup urine disease, Methylmalonic acidemia, Niemann-Pick Disease, type C1, Krabbe Disease, Ornithine transcarbamylase deficiency, Sjogren Larsson syndrome, Pelizeaus-Merzbacher disease, Pyruvate dehydrogenase deficiency, Nonketotic Hyperglycinemia and Fabry disease. Space constraints do not allow mention of all the disorders in which one of these modalities has been investigated, or where it would add value to diagnosis or disease progression.

Keywords

Genetics / inborn error of metabolism / MRI / Magnetic Resonance Spectroscopy / functional near infrared spectroscopy / functional MRI / diffusion tensor imaging / neuroimaging

References

[1] ButterworthRF.Effects of hyperammonaemia on brain function..J Inherit Metab Dis1998;21:6-20

[2] HoffmannGF,TrefzFK,BremerHJ.Neurological manifestations of organic acid disorders..Eur J Pediatr1994;153:S94-100

[3] KölkerS,OkunJG.Pathomechanisms of neurodegeneration in glutaryl-CoA dehydrogenase deficiency..Ann Neurol2004;55:7-12

[4] GropmanAL,LeonardJV.Neurological implications of urea cycle disorders..J Inherit Metab Dis2007;30:865-79 PMCID:PMC3758693

[5] KölkerS,HoffmannGF,MorathMA.Pathogenesis of CNS involvement in disorders of amino and organic acid metabolism..J Inherit Metab Dis2008;31:194-204

[6] PalermoL,MacDonaldA,HallSK.Cognitive outcomes in early-treated adults with phenylketonuria (PKU): a comprehensive picture across domains..Neuropsychology2017;31:255-67 PMCID:PMC5328133

[7] HofmanDL,LawtonCL,DyeL.A systematic review of cognitive functioning in early treated adults with phenylketonuria..Orphanet J Rare Dis2018;13:150 PMCID:PMC6117942

[8] SmithE,ThurmA.Prefrontal activation during executive tasks emerges over early childhood: evidence from functional near infrared spectroscopy..Dev Neuropsychol2017;42:253-64

[9] KimuraS,NezuA,YamazakiS.Two cases of glutaric aciduria type 1: Clinical and neuropathological findings..J Neurol Sci1994;123:38-43

[10] GropmanAL.The neurological presentations of childhood and adult mitochondrial disease: established syndromes and phenotypic variations..Mitochondrion2004;4:503-20

[11] HartingI,GebS.Looking beyond the basal ganglia: the spectrum of MRI changes in methylmalonic acidaemia..J Inherit Metab Dis2008;31:368-78

[12] HartwigV,TognettiA.Systematic review of fMRI compatible devices: design and testing criteria..Ann Biomed Eng2017;45:1819-35

[13] BasserPJ,LeBihanD.MR diffusion tensor spectroscopy and imaging..Biophys J1994;66:259-67 PMCID:PMC1275686

[14] BendlinBB,LazarM.Longitudinal changes in patients with traumatic brain injury assessed with diffusion-tensor and volumetric imaging..Neuroimage2008;42:503-14 PMCID:PMC2613482

[15] HahnLA.Working memory as an indicator for comparative cognition - detecting qualitative and quantitative differences..Front Psychol2020;11:1954 PMCID:PMC7424011

[16] DoyleCM,OrlowskaD.The neuropsychological profile of galactosaemia..J Inherit Metab Dis2010;33:603-9

[17] AhtamB,AnastasoaieV.Identification of neuronal structures and pathways corresponding to clinical functioning in galactosemia..J Inherit Metab Dis2020;

[18] Antenor-DorseyJA,RutlinJ.White matter integrity and executive abilities in individuals with phenylketonuria..Mol Genet Metab2013;109:125-31 PMCID:PMC3678378

[19] ChristSE,de SonnevilleLM.Executive function in early-treated phenylketonuria: profile and underlying mechanisms..Mol Genet Metab.2010;99 Suppl 1:S22-32

[20] YuQ,KangH.Differential white matter maturation from birth to 8 years of age..Cereb Cortex2020;30:2673-89 PMCID:PMC7175013

[21] KonoK,NakayamaK.Diffusion-weighted MR imaging in patients with phenylketonuria: relationship between serum phenylalanine levels and ADC values in cerebral white matter..Radiology2005;236:630-6

[22] PengH,WhiteDA.Tract-based evaluation of white matter damage in individuals with early-treated phenylketonuria..J Inherit Metab Dis2014;37:237-43

[23] VermathenP,PietzJ,BoeschC.Characterization of white matter alterations in phenylketonuria by magnetic resonance relaxometry and diffusion tensor imaging..Magn Reson Med2007;58:1145-56

[24] WhiteDA,GrangeDK.White matter integrity and executive abilities following treatment with tetrahydrobiopterin (BH4) in individuals with phenylketonuria..Mol Genet Metab2013;110:213-7 PMCID:PMC3832288

[25] WhiteDA,NardosB.Age-related decline in the microstructural integrity of white matter in children with early- and continuously-treated PKU: a DTI study of the corpus callosum..Mol Genet Metab.2010;99 Suppl 1:S41-6 PMCID:PMC3640282

[26] AndersonPJ,FrancisDE,AndersonV.Are neuropsychological impairments in children with early-treated phenylketonuria (PKU) related to white matter abnormalities or elevated phenylalanine levels?.Dev Neuropsychol2007;32:645-68

[27] HoodA,ShimonyJS,WhiteDA.MoravaE,PattersonM,ZschockeJ.Brain white matter integrity mediates the relationship between phenylalanine control and executive abilities in children with phenylketonuria..JIMD Reports, Volume 33.2017;BerlinSpringer Berlin Heidelberg41-7 PMCID:PMC5413446

[28] HoodA,RutlinJ.Prolonged exposure to high and variable phenylalanine levels over the lifetime predicts brain white matter integrity in children with phenylketonuria..Mol Genet Metab2015;114:19-24 PMCID:PMC4277899

[29] LeuzziV,MontanaroD.The pathogenesis of the white matter abnormalities in phenylketonuria. A multimodal 3.0 tesla MRI and magnetic resonance spectroscopy (¹H MRS) study..J Inherit Metab Dis2007;30:209-16

[30] LeuzziV,FabbriziF.Neuroradiological (MRI) abnormalities in phenylketonuric subjects: clinical and biochemical correlations..Neuropediatrics1993;24:302-6

[31] ManaraR,CittonV.Brain MRI diffusion-weighted imaging in patients with classical phenylketonuria..Neuroradiology2009;51:803-12

[32] RuppA,ZschockeJ.Variability of blood-brain ratios of phenylalanine in typical patients with phenylketonuria..J Cereb Blood Flow Metab2001;21:276-84

[33] ScarabinoT,TosettiM.Phenylketonuria: white-matter changes assessed by 3.0-T magnetic resonance (MR) imaging, MR spectroscopy and MR diffusion..Radiol Med2009;114:461-74

[34] SundermannB,DehghanNayyeri M.Approaching altered inhibitory control in phenylketonuria: a functional MRI study with a Go-NoGo task in young female adults..Eur J Neurosci2020;52:3951-62

[35] NardecchiaF,ChiarottiF,CarducciC.Neurocognitive and neuroimaging outcome of early treated young adult PKU patients: a longitudinal study..Mol Genet Metab2015;115:84-90

[36] DingXQ,KohlschütterB.MRI abnormalities in normal-appearing brain tissue of treated adult PKU patients..J Magn Reson Imaging2008;27:998-1004

[37] SchadewaldtP.Metabolism of branched-chain amino acids in maple syrup urine disease..Eur J Pediatr.1997;156 Suppl 1:S62-6

[38] HarrisRA,JeoungNH.Overview of the molecular and biochemical basis of branched-chain amino acid catabolism..J Nutr2005;135:1527S-30

[39] JanW,WangZJ,KaplanPB.MR diffusion imaging and MR spectroscopy of maple syrup urine disease during acute metabolic decompensation..Neuroradiology2003;45:393-9

[40] HaJS,EunBL.Maple syrup urine disease encephalopathy: a follow-up study in the acute stage using diffusion-weighted MRI..Pediatr Radiol2004;34:163-6

[41] RighiniA,PariniR,MoscaF.Water apparent diffusion coefficient and T2 changes in the acute stage of maple syrup urine disease: evidence of intramyelinic and vasogenic-interstitial edema..J Neuroimaging2003;13:162-5

[42] ParmarH,HoL.Maple syrup urine disease: diffusion-weighted and diffusion-tensor magnetic resonance imaging findings..J Comput Assist Tomogr2004;28:93-7

[43] GaoY,WangJ,LiYH.Fractional anisotropy for assessment of white matter tracts injury in methylmalonic acidemia..Chin Med J (Engl)2009;122:945-9

[44] LauMW,MiyamotoR.Role of diffusion tensor imaging in prognostication and treatment monitoring in niemann-pick disease type C1..Diseases2016;4:29 PMCID:PMC5456286

[45] PorettiA,FatemiA.Diffusion tensor imaging: a biomarker of outcome in Krabbe’s disease..J Neurosci Res2016;94:1108-15

[46] GropmanAL,ShattuckK.Diffusion tensor imaging detects areas of abnormal white matter microstructure in patients with partial ornithine transcarbamylase deficiency..AJNR Am J Neuroradiol2010;31:1719-23 PMCID:PMC3758695

[47] MiscevicF,SchmittB,BrudnoM.An MRspec database query and visualization engine with applications as a clinical diagnostic and research tool..Mol Genet Metab2016;119:300-6

[48] GropmanAL.Expanding the diagnostic and research toolbox for inborn errors of metabolism: the role of magnetic resonance spectroscopy..Mol Genet Metab2005;86:2-9

[49] RossBD.New aspects of brain physiology..NMR Biomed1996;9:279-96

[50] ManoT,KaminagaT.Proton MR spectroscopy of Sjögren-Larsson’s syndrome..AJNR1999;20:1671-3

[51] BoyN,HeringerJ,KölkerS.Patterns, evolution, and severity of striatal injury in insidious- vs acute-onset glutaric aciduria type 1..J Inherit Metab Dis2019;42:117-27

[52] HeindelW,WendelU,Benz-BohmG.Proton magnetic resonance spectroscopy reflects metabolic decompensation in maple syrup urine disease..Pediatr Radiol1995;25:296-9

[53] SatoT,HanakawaJ.Neonatal case of classic maple syrup urine disease: usefulness of (1) H-MRS in early diagnosis..Pediatr Int2014;56:112-5

[54] CecilKM.Magnetic resonance spectroscopy and metabolic imaging in white matter diseases and pediatric disorders..Top Magn Reson Imaging2006;17:275-93

[55] TakanashiJ,OsakaH,NiimiH.Proton MR spectroscopy in Pelizaeus Merzbacher disease..AJNR1997;18:533-5

[56] PizziniF,BarkerPB.Proton MR spectroscopic imaging in Pelizaeus Merzbacher disease..AJNR2003;24:1683-9

[57] SenerR.Pelizaeus-Merzbacher disease: diffusion MR imaging and proton MR spectroscopy findings..J Neuroradiol2004;31:138-41

[58] ManoliI,VendittiCP.AdamMP,PagonRA,BeanLJH,AmemiyaA.Isolated methylmalonic acidemia. 2005 Aug 16 [updated 2016 Dec 1]..GeneReviews® [Internet].1993-2020;Seattle (WA)University of Washington

[59] de SousaC,BrettEM.Focal changes in the globi pallidi associated with neurological dysfunction in methylmalonic acidaemia..Neuropediatrics1989;20:199-201

[60] BakerEH,HauserNS.MRI characteristics of globus pallidus infarcts in isolated methylmalonic acidemia..AJNR Am J Neuroradiol2015;36:194-201

[61] TakeuchiM,MatsuzakiK,NishitaniH.Magnetic resonance imaging and spectroscopy in a patient with treated methylmalonic acidemia..J Comput Assist Tomogr2003;27:547-51

[62] ByronO.HarrisJR.The pyruvate dehydrogenase complex and related assemblies in health and disease..Macromolecular protein complexes.2017;ChamSpringer International Publishing523-50

[63] SofouK,WiklundLM,DarinN.MRI of the brain in childhood-onset mitochondrial disorders with central nervous system involvement..Mitochondrion2013;13:364-71

[64] Rubio-GozalboM,TrijbelsJ,ThijssenH.Proton MR spectroscopy in a child with pyruvate dehydrogenase complex deficiency..Magnetic Resonance Imaging1999;17:939-44

[65] StenceNV,LevekC.Brain imaging in classic nonketotic hyperglycinemia: quantitative analysis and relation to phenotype..J Inherit Metab Dis2019;42:438-50

[66] DobynsWB.Agenesis of the corpus callosum and gyral malformations are frequent manifestations of nonketotic hyperglycinemia..Neurology1989;39:817-20

[67] TakanashiJ,TomitaM.Distinctly abnormal brain metabolism in late-onset ornithine transcarbamylase deficiency..Neurology2002;59:210-4

[68] GropmanAL,SeltzerRR.¹H MRS identifies symptomatic and asymptomatic subjects with partial ornithine transcarbamylase deficiency..Mol Genet Metab2008;95:21-30 PMCID:PMC3724938

[69] GropmanAL,YudkoffM,VanMeterJ.¹H MRS allows brain phenotype differentiation in sisters with late onset ornithine transcarbamylase deficiency (OTCD) and discordant clinical presentations..Mol Genet Metab2008;94:52-60 PMCID:PMC2486377

[70] BaileyDL,ValkPE.Positron emission tomography: basic sciences.2005;Secaucus, NJSpringer-Verlag

[71] MillerJJ,DahmsNM.Progress in the understanding and treatment of Fabry disease..Biochim Biophys Acta Gen Subj2020;1864:129437 PMCID:PMC6981246

[72] Feldt-RasmussenU.Fabry disease and early stroke..Stroke Res Treat2011;2011:615218 PMCID:PMC3138050

[73] MitsiasP.Cerebrovascular complications of Fabry’s disease..Ann Neurol1996;40:8-17

[74] CrutchfieldKE,DambrosiaJM.Quantitative analysis of cerebral vasculopathy in patients with Fabry disease..Neurology1998;50:1746-9

[75] MooreDF,AskariH.The cerebral vasculopathy of Fabry disease..J Neurol Sci2007;257:258-63

[76] DeGrabaT,gnat-GeorgeF.Profile of endothelial and leukocyte activation in Fabry patients..Ann Neurol2000;47:229-33

[77] SchiffmannR.Fabry disease..Pharmacol Ther2009;122:65-77

[78] KorsholmK,GranqvistH.Positron emission tomography and magnetic resonance imaging of the brain in fabry disease: a nationwide, long-time, prospective follow-up..PLoS One2015;10:e0143940 PMCID:PMC4667906

[79] FiciciogluC,ThomasN.A pilot study of fluorodeoxyglucose positron emission tomography findings in patients with phenylketonuria before and during sapropterin supplementation..J Clin Neurol2013;9:151-6 PMCID:PMC3722466

[80] FriedlandRP.Roy and Sherrington (1890): a centennial reexamination of “On the regulation of the blood-supply of the brain”..Neurology1991;41:10-4

[81] LogothetisNK.What we can do and what we cannot do with fMRI..Nature2008;453:869-78

[82] MazoyerB,MelletE.Cortical networks for working memory and executive functions sustain the conscious resting state in man..Brain Res Bull2001;54:287-98

[83] RaichleME.A default mode of brain function: a brief history of an evolving idea..Neuroimage2007;37:1083-90discussion 1097-9

[84] KonishiM,EngenH.Shaped by the past: the default mode network supports cognition that is independent of immediate perceptual input..PLoS One2015;10:e0132209 PMCID:PMC4488375

[85] Andrews-HannaJR.The brain’s default network and its adaptive role in internal mentation..Neuroscientist2012;18:251-70 PMCID:PMC3553600

[86] BucknerRL,SchacterDL.The brain’s default network: anatomy, function, and relevance to disease..Ann N Y Acad Sci2008;1124:1-38

[87] ChristSE,PeckD.Disruption of prefrontal function and connectivity in individuals with phenylketonuria..Mol Genet Metab.2010;99 Suppl 1:S33-40

[88] ChristSE,PeckD,HilgardJ.Decreased functional brain connectivity in individuals with early-treated phenylketonuria: evidence from resting state fMRI..J Inherit Metab Dis2012;35:807-16

[89] van ErvenB,Rubio-GozalboME.Exploration of the brain in rest: resting-state functional MRI abnormalities in patients with classic galactosemia..Sci Rep2017;7:9095 PMCID:PMC5567355

[90] Pacheco-ColónI,SprouseC,GropmanAL.Reduced functional connectivity of default mode and set-maintenance networks in ornithine transcarbamylase deficiency..PLoS One2015;10:e0129595 PMCID:PMC4466251

[91] GropmanAL,PrustMJ.Altered neural activation in ornithine transcarbamylase deficiency during executive cognition: an fMRI study..Hum Brain Mapp2013;34:753-61 PMCID:PMC3338900

[92] Lloyd-FoxS,ElwellCE.Illuminating the developing brain: the past, present and future of functional near infrared spectroscopy..Neurosci Biobehav Rev2010;34:269-84

[93] WilcoxT.fNIRS in the developmental sciences..Wiley Interdiscip Rev Cogn Sci2015;6:263-83 PMCID:PMC4979552

[94] AslinRN.Near-infrared spectroscopy for functional studies of brain activity in human infants: promise, prospects, and challenges..J Biomed Opt2005;10:11009

[95] RamanS,DeVileC,RahmanS.Near infrared spectroscopy with a vascular occlusion test as a biomarker in children with mitochondrial and other neuro-genetic disorders..PLoS One2018;13:e0199756 PMCID:PMC6029804

[96] AndersonA,Le MonsC,GandjbakhcheA.Evaluation of neurocognitive function of prefrontal cortex in ornithine transcarbamylase deficiency..Mol Genet Metab2020;129:207-12 PMCID:PMC7416502

[97] DavisonJE,WilsonM.MR spectroscopy-based brain metabolite profiling in propionic acidaemia: metabolic changes in the basal ganglia during acute decompensation and effect of liver transplantation..Orphanet J Rare Dis2011;6:19 PMCID:PMC3113316

[98] Diamond A. Normal development of prefrontal cortex from birth to young adulthood: Cognitive functions, anatomy, and biochemistry. Principles of frontal lobe function 2002: 466-503. Available from: https://psycnet.apa.org/record/2002-17547-028. [Last accessed on 4 Nov 2020]